Treatment of Staphylococcus aureus keratitis with 0.2% topical linezolid
Descripción del Articulo
Objective: To reportthe use of 0.2% topical linezolid in the treatment of Staphylococcus aureuskeratitis with successful results. Material and Methods: All cases were viewed in Centro Vision, here they underwent a complete ophthalmic examination and were diagnosed with Staphylococcus aureus keratiti...
Autor: | |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2015 |
Institución: | Universidad de San Martín de Porres |
Repositorio: | Horizonte médico |
Lenguaje: | español |
OAI Identifier: | oai:horizontemedico.usmp.edu.pe:article/301 |
Enlace del recurso: | https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/301 |
Nivel de acceso: | acceso abierto |
Materia: | Bacterial keratitis Staphylococcus aureus Vancomycin Linezolid Queratitis bacteriana Vancomicina |
id |
REVHM_8db30d7df37e715d57fb2cf9eafad2e6 |
---|---|
oai_identifier_str |
oai:horizontemedico.usmp.edu.pe:article/301 |
network_acronym_str |
REVHM |
network_name_str |
Horizonte médico |
repository_id_str |
|
spelling |
Treatment of Staphylococcus aureus keratitis with 0.2% topical linezolidTratamiento de queratitis bacteriana por Staphylococcus aureus con linezolid 0.2% tópicoLavado Landeo, LincolnBacterial keratitisStaphylococcus aureusVancomycinLinezolidQueratitis bacterianaStaphylococcus aureusVancomicinaLinezolidObjective: To reportthe use of 0.2% topical linezolid in the treatment of Staphylococcus aureuskeratitis with successful results. Material and Methods: All cases were viewed in Centro Vision, here they underwent a complete ophthalmic examination and were diagnosed with Staphylococcus aureus keratitis based on a microbiological study. In both cases we began with the gold standard therapy based on fortified topical drops of vancomycin and an aminoglycoside. Due to ineffective action and/or poor tolerance of vancomycin, we decided to use topical linezolid. Results: Two female patients with Staphylococcus aureus keratitis received ocular 0.2% topical linezolid every hour. In both cases we saw a marked clinical improvement and a good tolerance to this antibiotic. Conclusion: 0.2% Topical linezolid is an effective and well tolerated antibiotic when used in the treatment of Staphylococcus aureus keratitis. It is more comfortable and less toxic than topical vancomycin.Objetivo: Reportar el uso tópico ocular de linezolid 0.2% para el tratamiento de queratitis por Staphylococcus aureus con resultados exitosos. Material y Métodos: Todos los casos acudieron a Centro Visión, a ambas pacientes se les realizó un examen oftalmológico completo y se les diagnosticó queratitis por Staphylococcus aureus basado en un estudio microbiológico. En ambos casos se inició con la terapia estándar basada en gotas tópicas fortificadas de vancomicina y un aminoglucósido. Debido a una inefectiva acción y/o una pobre tolerancia antibiótica de la vancomicina se optó por el uso de linezolid tópico. Resultados: Dos pacientes de sexo femenino con el diagnóstico de queratitis por Staphylococcus aureus recibieron linezolid 0.2% tópico ocular cada hora. En ambos casos se apreció una marcada mejoría clínica y una buena tolerancia antibiótica. Conclusión: El linezolid 0.2% tópico es un antibiótico efectivo y muy bien tolerado cuando es usado en el tratamiento de queratitis por Staphylococcus aureus. El linezolid tópico es más confortable y menos tóxico que la vancomicina tópica.Universidad de San Martín de Porres. Facultad de Medicina Humana2015-09-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/30110.24265/horizmed.2015.v15n3.08Horizonte Médico (Lima); Vol. 15 No. 3 (2015): July - September; 46-50Horizonte Médico (Lima); Vol. 15 Núm. 3 (2015): Julio - Setiembre; 46-50Horizonte Médico (Lima); v. 15 n. 3 (2015): Julio - Setiembre; 46-502227-35301727-558X10.24265/horizmed.2015.v15n3reponame:Horizonte médicoinstname:Universidad de San Martín de Porresinstacron:USMPspahttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/301/289Derechos de autor 2015 Horizonte Médico (Lima)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:horizontemedico.usmp.edu.pe:article/3012022-08-03T18:17:39Z |
dc.title.none.fl_str_mv |
Treatment of Staphylococcus aureus keratitis with 0.2% topical linezolid Tratamiento de queratitis bacteriana por Staphylococcus aureus con linezolid 0.2% tópico |
title |
Treatment of Staphylococcus aureus keratitis with 0.2% topical linezolid |
spellingShingle |
Treatment of Staphylococcus aureus keratitis with 0.2% topical linezolid Lavado Landeo, Lincoln Bacterial keratitis Staphylococcus aureus Vancomycin Linezolid Queratitis bacteriana Staphylococcus aureus Vancomicina Linezolid |
title_short |
Treatment of Staphylococcus aureus keratitis with 0.2% topical linezolid |
title_full |
Treatment of Staphylococcus aureus keratitis with 0.2% topical linezolid |
title_fullStr |
Treatment of Staphylococcus aureus keratitis with 0.2% topical linezolid |
title_full_unstemmed |
Treatment of Staphylococcus aureus keratitis with 0.2% topical linezolid |
title_sort |
Treatment of Staphylococcus aureus keratitis with 0.2% topical linezolid |
dc.creator.none.fl_str_mv |
Lavado Landeo, Lincoln |
author |
Lavado Landeo, Lincoln |
author_facet |
Lavado Landeo, Lincoln |
author_role |
author |
dc.subject.none.fl_str_mv |
Bacterial keratitis Staphylococcus aureus Vancomycin Linezolid Queratitis bacteriana Staphylococcus aureus Vancomicina Linezolid |
topic |
Bacterial keratitis Staphylococcus aureus Vancomycin Linezolid Queratitis bacteriana Staphylococcus aureus Vancomicina Linezolid |
description |
Objective: To reportthe use of 0.2% topical linezolid in the treatment of Staphylococcus aureuskeratitis with successful results. Material and Methods: All cases were viewed in Centro Vision, here they underwent a complete ophthalmic examination and were diagnosed with Staphylococcus aureus keratitis based on a microbiological study. In both cases we began with the gold standard therapy based on fortified topical drops of vancomycin and an aminoglycoside. Due to ineffective action and/or poor tolerance of vancomycin, we decided to use topical linezolid. Results: Two female patients with Staphylococcus aureus keratitis received ocular 0.2% topical linezolid every hour. In both cases we saw a marked clinical improvement and a good tolerance to this antibiotic. Conclusion: 0.2% Topical linezolid is an effective and well tolerated antibiotic when used in the treatment of Staphylococcus aureus keratitis. It is more comfortable and less toxic than topical vancomycin. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-09-17 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/301 10.24265/horizmed.2015.v15n3.08 |
url |
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/301 |
identifier_str_mv |
10.24265/horizmed.2015.v15n3.08 |
dc.language.none.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/301/289 |
dc.rights.none.fl_str_mv |
Derechos de autor 2015 Horizonte Médico (Lima) https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Derechos de autor 2015 Horizonte Médico (Lima) https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidad de San Martín de Porres. Facultad de Medicina Humana |
publisher.none.fl_str_mv |
Universidad de San Martín de Porres. Facultad de Medicina Humana |
dc.source.none.fl_str_mv |
Horizonte Médico (Lima); Vol. 15 No. 3 (2015): July - September; 46-50 Horizonte Médico (Lima); Vol. 15 Núm. 3 (2015): Julio - Setiembre; 46-50 Horizonte Médico (Lima); v. 15 n. 3 (2015): Julio - Setiembre; 46-50 2227-3530 1727-558X 10.24265/horizmed.2015.v15n3 reponame:Horizonte médico instname:Universidad de San Martín de Porres instacron:USMP |
instname_str |
Universidad de San Martín de Porres |
instacron_str |
USMP |
institution |
USMP |
reponame_str |
Horizonte médico |
collection |
Horizonte médico |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1841556062044422144 |
score |
13.448654 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).